Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2025-12-24 @ 11:45 AM
NCT ID:
NCT02817061
Eligibility Criteria:
Inclusion Criteria:
* Age: 18-25 or 65-85
* Women of child-bearing potential, must use a double-barrier method for birth control (e.g. condoms with spermicide) if sexually active during the study and for 30 days post treatment of any kind.
* Subject Informed Consent obtained in writing in compliance with local regulations prior to enrollment into this study.
* The subject (and caregiver, if applicable) is willing to participate in this study for at least 12 weeks.
Exclusion Criteria:
* Inability to speak or read English (necessary for cognitive testing software use).
* Pregnancy or lactation
* History of stroke or traumatic brain injury
* Substance dependence or abuse in the past 6 months
* Diagnosis with major psychiatric disease (Psychotic disorder or psychotic episode, bipolar affective disorder)
* Diagnosed with a neurodevelopmental condition (autism or ADHD)
* A traumatic event that resulted in PTSD
* Any unstable medical illness (defined as any medical illness which has not been well-controlled with standard-of-care medications)
* A significant skin condition (i.e., hemangioma, scleroderma, rash, open wound) or medical implant (e.g. metal plate, implantable shunt or valve) on the head.
* Inability to understand or participate in the consent and performance of the study.
* Those with Parkinson's Disease, End Stage Renal Disease, and/or End Stage Liver Disease
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02817061
Study Brief:
Protocol Section:
NCT02817061